Biopol Chemicals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Revenue	811.43	492.21	174.33
Revenue Growth	64.85%	182.35%	-
Cost of Revenue	631.26	403.03	146.42
Gross Profit	180.17	89.18	27.91
Selling, General & Admin	23.33	14.34	3.5
Other Operating Expenses	21.59	10.01	5.62
Operating Expenses	45.91	25.27	9.52
Operating Income	134.27	63.92	18.38
Interest Expense	-12.35	-4.52	-0.81
Interest & Investment Income	1.05	-	-
Currency Exchange Gain (Loss)	0.47	-0.07	-0.02
Other Non Operating Income (Expenses)	-2.85	-1.53	-0.43
Pretax Income	120.58	57.8	17.12
Income Tax Expense	30.84	14.68	4.31
Net Income	89.74	43.12	12.81
Net Income to Common	89.74	43.12	12.81
Net Income Growth	108.11%	236.69%	-
Shares Outstanding (Basic)	8	8	-
Shares Outstanding (Diluted)	8	8	-
Shares Change	4.72%	-	-
EPS (Basic)	10.83	5.45	-
EPS (Diluted)	10.83	5.45	-
EPS Growth	98.72%	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Free Cash Flow	-269.66	-24.38	-89.43
Free Cash Flow Per Share	-32.54	-3.08	-
Gross Margin	22.20%	18.12%	16.01%
Operating Margin	16.55%	12.99%	10.54%
Profit Margin	11.06%	8.76%	7.35%
Free Cash Flow Margin	-33.23%	-4.95%	-51.30%
EBITDA	135.25	64.84	18.78
EBITDA Margin	16.67%	13.17%	10.77%
D&A For EBITDA	0.98	0.92	0.4
EBIT	134.27	63.92	18.38
EBIT Margin	16.55%	12.99%	10.54%
Effective Tax Rate	25.58%	25.40%	25.19%
Revenue as Reported	813.72	492.21	174.33